by MaryBeth DiDonna, Editor
Size: 27,000 sf
Project team: DPS Group (engineering, architectural services), Hodess Cleanroom Construction (construction, prime consultant)
Description: Mustang Bio’s new CAR T and gene therapy development facility is located within UMass Medicine Science Park in Worcester. It will support the clinical development and commercialization of Mustang’s CAR T and gene therapy product candidates and enable proprietary cell therapy research.
The project focused on upgrading existing office and laboratory space, and converting existing labs into three cGMP ISO 7 clinical production areas. The flexible design met Mustang’s current workplace and manufacturing needs in approximately 12,000 sf of the facility, providing ample space for future expansion.
Other facility improvements included HVAC, mechanical, and fire protection system upgrades and the installation of a new air handling unit customized for increased air flow to the cGMP spaces. Energy efficient lighting and lighting controls were also added.
The cell therapy manufacturing facility will enable the company to process personalized cell therapies for the treatment of aggressive forms of cancer and continue to advance the research in support of gene therapy for X-linked severe combined immunodeficiency (X-SCID).
Completion date: November 2018
Contact: Valerie Capone, DPS Group, 508-861-3753, [email protected]
Follow this link to the article: https://www.rdmag.com/news/2018/11/facility-profile-mustang-bio-cell-therapy-manufacturing-facility